This document describes preclinical screening models used to evaluate potential antidepressant drugs. It discusses depression and currently used antidepressants. It then describes in vivo models like the forced swim test and tail suspension test used to screen drugs in rats and mice by measuring immobility time. In vitro models described involve measuring the inhibition of neurotransmitter reuptake like serotonin and norepinephrine in rat brain tissue preparations to determine a drug's ability to inhibit reuptake. These preclinical screening models are crucial for developing more effective antidepressant treatments.